AWARD NUMBER: W81XWH-10-1-0544 TITLE: Biomarkers in the Detection of Prostate Cancer in African Americans PRINCIPAL INVESTIGATOR:
نویسندگان
چکیده
Exosomes are small bilayer-membrane-bound nanoparticles that are released from normal, diseased, and neoplastic cells and are present in blood and other bodily fluids. Exosomes contain a variety of signal molecules including signal peptides, mRNA, microRNA (miRNA), and lipids and have characteristic molecular features on their external surfaces (e.g., CD9 and CD81). Exosomes can function to export from cells unneeded endogenous molecules and therapeutic drugs. When exosomes and similar types of vesicles are secreted from cells and are taken up by other cells, they may act locally to provide autocrine or paracrine signals or distantly as a newly described nanoparticle-based endocrine system. Specifically, mRNA transferred to cells by exosomes can result in the production of new and novel proteins. In cancer, signals via exosomes affect the immune system via inhibition of the functions of T cells and natural killer (NK) cells, by inhibiting the differentiation of precursors to mature antigen-presenting cells, e.g., dendritic cells, and by increasing the number and/or activity of immune suppressor cells including myeloid-derived suppressor cells, T regulatory cells, and CD14, HLA-DR−/low cells. Exosomes from neoplastic lesions also act to provide a fertile environment in which neoplastic lesions can develop, progress, and metastasize, especially via the stimulation of angiogenesis. Exosomes have multiple potential clinical uses including the development of vaccines for targeting tumors; also, tumor-derived exosomes may be useful in diagnosis/early detection, risk assessment and prediction, in determining prognosis, and as surrogate endpoints in evaluating therapeutic and preventive approaches to cancer.
منابع مشابه
Award Number: W81XWH-12-1-0245 TITLE: Evaluation of Multimodal Imaging Biomarkers of Prostate Cancer PRINCIPAL INVESTIGATOR:
متن کامل
AWARD NUMBER: W81XWH-05-1-0167 TITLE: Prostate Cancer Detection by Molecular Urinalysis PRINCIPAL INVESTIGATOR: Christian Pavlovich, M.D
متن کامل
AWARD NUMBER: W81XWH-14-1-0576 TITLE: Understanding and Targeting Tumor Microenvironment in Prostate Cancer to Inhibit Tumor Progression and Castration Resistance PRINCIPAL INVESTIGATOR: Lu, Xin CONTRACTING ORGANIZATION: MD Anderson Cancer Center
متن کامل
AWARD NUMBER: W81XWH-14-1-0576 TITLE: Understanding and Targeting Tumor Microenvironment in Prostate Cancer to Inhibit Tumor Progression and Castration Resistance PRINCIPAL INVESTIGATOR:
TITLE: Understanding and Targeting Tumor Microenvironment in Prostate Cancer to Inhibit Tumor Progression and Castration Resistance PRINCIPAL INVESTIGATOR: Lu, Xin CONTRACTING ORGANIZATION: The University of Texas MD Anderson Cancer Center Houston, TX 77030 REPORT DATE: October 2015 TYPE OF REPORT: Annual PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702...
متن کاملAWARD NUMBER: W81XWH-11-1-0713 TITLE: Identification of Novel, Inherited Genetic Markers for Aggressive PCa in European and African Americans Using Whole Genome Sequencing PRINCIPAL INVESTIGATOR:
متن کامل
Award Number : W 81 XWH - 08 - 1 - 0030 TITLE : Regulation of Prostate Cancer Bone Metastasis by DKK 1 PRINCIPAL INVESTIGATOR : Gregory A . Clines
Award Number: W81XWH-08-1-0030 TITLE: Regulation of Prostate Cancer Bone Metastasis by DKK1 PRINCIPAL INVESTIGATOR: Gregory A. Clines, M.D., Ph.D. CONTRACTING ORGANIZATION: University of Alabama at Birmingham Birmingham, AL 35294-0111 REPORT DATE: April 2012 TYPE OF REPORT: Annual PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEM...
متن کامل